Articles Published in 2011 Articles | CenterWatch News Online

Articles Published in 2011

Prev 10 11 12 13 14 15 16 17 18 19 20 Next 10

The CenterWatch Monthly, December 2011

Thursday, December 1, 2011 09:46 AM

Canada scrambles to reboot sagging clinical trials market

More... »

Onconova extends agreement with BioClinica

Wednesday, November 30, 2011 02:54 PM

BioClinica has reported that Onconova Therapeutics has extended agreements using BioClinica Express electronic data capture (EDC) and data management services to support their clinical trials world-wide. Onconova has a number of clinical-stage products and a growing number of pre-clinical candidates. These development stage compounds are novel small molecules for the treatment of a broad range of hematologic malignancies and solid tumors.

More... »

Leonardo Biosystems, NanoMedical Systems collaborate

Wednesday, November 30, 2011 02:28 PM

Leonardo Biosystems and NanoMedical Systems have signed a development contract in which NMS will develop and establish a commercial process to manufacture nanoporous silicon particles for Leonardo's multi-stage drug delivery system.

More... »

BioMarin initiates phase II GALNS study

Wednesday, November 30, 2011 01:09 PM

BioMarin Pharmaceutical has initiated a phase II study for GALNS (N-acetylgalactosamine 6-sulfatase) in patients under five years of age with mucopolysaccharidosis IVA (MPS IVA).

More... »

Omeros unlocks 20% of Class A orphans

Wednesday, November 30, 2011 01:02 PM

Omeros has reported that with its identification of compounds that interact
selectively with each of four additional orphan G protein-coupled receptors (GPCRs) - GPR19, GPR20, GPR31 and GPR141 - it has now unlocked over 20% of the 77 Class A orphans. GPCRs represent the premier family of drug targets, with more than 30% of currently marketed drugs targeting only 46 GPCRs. There are approximately 120 orphan GPCRs, and Omeros is initially targeting Class A orphan GPCRs.

More... »

Rhythm names chief scientific officer

Wednesday, November 30, 2011 12:40 PM

Rhythm has named Lex Van der Ploeg, PhD, chief scientific officer. Van der Ploeg brings to Rhythm more than 25 years of drug development experience in obesity, metabolic diseases, and other therapeutic areas.

More... »

AIT Bioscience, PreClinOmics forge working partnership

Wednesday, November 30, 2011 11:30 AM

AIT Bioscience, a bioanalytical contract research organization and PreClinOmics, a preclinical contract research company have forged a working partnership.

More... »

AstraZeneca, Cognizant sign multi-year agreement

Wednesday, November 30, 2011 11:10 AM

Cognizant, a provider of consulting, technology, and business process outsourcing services, has signed a multi-year agreement with AstraZeneca to deliver comprehensive biostatistics and medical reporting services to generate clinical study reports.

More... »

Medicines Australia presents clinical trial recommendations to the Federal Government

Wednesday, November 30, 2011 10:55 AM

A Medicines Australia paper launched at Parliament House shows the Federal Government’s plan to invigorate the clinical trials industry is working but that implementation must be completed.

More... »

Imperial College and providers form partnership to improve healthcare in London

Wednesday, November 30, 2011 10:38 AM

Imperial College London and healthcare providers in North West London plan to form a partnership to improve the health and care of the local population of 1.9 million people.

More... »